SCHEMBL20797650

SCHEMBL20797650

CCN(CC)c1ncc(C=O)cc1F

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.43
▸ ALDH1A3 P47895 4/20 0.43
▸ ALDH3A1 P30838 4/20 0.43
▸ L3MBTL1 Q9Y468 3/20 0.35
▸ HTT P42858 2/20 0.35
▸ PTGER4 P35408 2/20 0.33
▸ POLB P06746 1/20 0.31
▸ CASP6 P55212 1/20 0.31
▸ ALOX15 P16050 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ GAA P10253 1/20 0.30
▸ TERT O14746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17696428 0.77 ALOX15 (0.33) ALDH1A1HTTALOX15SMN1; SMN2MEN1
SCHEMBL21546435 0.75 GBA1 (0.46) ALDH1A1HTTALOX15SMN1; SMN2KDM4E
SCHEMBL23570033 0.75 PGK1 (0.35) L3MBTL1ALOX15SMN1; SMN2KDM4EKMT2A
SCHEMBL336656 0.73 PTGER4 (0.36) ALDH1A1ALDH1A3ALDH3A1L3MBTL1PTGER4
SCHEMBL17693920 0.72 CRHR1 (0.34) ALDH1A1HTTALOX15SMN1; SMN2TERT
SCHEMBL335669 0.72 ALDH1A1 (0.37) ALDH1A1L3MBTL1PTGER4POLBCASP6
SCHEMBL29955433 0.72 ALDH1A1 (0.37) ALDH1A1L3MBTL1PTGER4POLBCASP6
SCHEMBL30013048 0.71 ALDH1A1 (0.37) ALDH1A1L3MBTL1PTGER4POLBCASP6
SCHEMBL29954177 0.71 ALDH1A1 (0.37) ALDH1A1L3MBTL1PTGER4POLBCASP6
SCHEMBL22666896 0.70 ALDH1A1 (0.40) ALDH1A1L3MBTL1PTGER4POLBCASP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019049061-A1 5-(1 H-BENZO[D]IMIDAZO-2-YL)-PYRIDIN-2-AMINE AND 5-(3H-IMIDAZO[4,5-B]PYRIDIN-6-YL)-PYRIDIN-2-AMINE DERIVATIVES AS C-MYC AND P300/CBP HISTONE ACETYLTRANSFERASE INHIBITORS FOR TREATING CANCER GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2019-03-14 — — WO disclosed
WO-2019049061-A1 5-(1 H-BENZO[D]IMIDAZO-2-YL)-PYRIDIN-2-AMINE AND 5-(3H-IMIDAZO[4,5-B]PYRIDIN-6-YL)-PYRIDIN-2-AMINE DERIVATIVES AS C-MYC AND P300/CBP HISTONE ACETYLTRANSFERASE INHIBITORS FOR TREATING CANCER GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2019-03-14 — — WO disclosed
Send feedback